Sonoma Pharmaceuticals Cancels Adjourned Special Stockholder MeetingTip Ranks·1 day ago, 04:48 PMSNOA-1.47%
Sonoma Pharmaceuticals special shareholder meeting lacked quorum, chairman canceled sessionPUBT·1 day ago, 04:30 PMSNOA-1.47%
Sonoma FY2027 Q1 earnings: 60% revenue growth moves EBITDA positiveTradingKey·Aug 6 at 08:34 AMSNOA-1.47%
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenuebenzinga_article·Aug 6 at 07:33 AMSNOA-1.47%
Sonoma Pharma FY27 Q1 net loss narrows 73.41% to USD 330,000; revenue rises 60% to USD 6.41 millionPUBT·Aug 6 at 07:32 AMSNOA-1.47%
Sonoma Pharma wins FDA 510(k) clearance expanding Microdacyn wound solution indicationsPUBT·Jun 30 at 08:01 AMSNOA-1.47%
Sonoma Pharmaceuticals Expands At-the-Market Equity Offering CapacityTip Ranks·Jun 18 at 05:41 PMSNOA-1.47%
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | SNOA Stock NewsStockTitan·Jun 16 at 07:15 AMSNOA-1.47%
